Artificial pancreas: a game changer in the diabetic management

Sumanth Marupuru; Veeraj Dudem; Zeal Soni; Dhruvi Doshi; Srikar Reddy Vummenthala; Vaishnavi Gummalla

doi:10.18203/2349-3933.ijam20243071

Authors

Sumanth Marupuru Sri Venkateswara Medical College, Alipiri Road Srinivasa Nagar, Tirupati, Andhra Pradesh, India
Veeraj Dudem Department of Medicine, Prathima Institute of Medical Sciences (PIMS), Karimnagar, India
Zeal Soni Smt NHL Municipal Medical College, Ahmedabad, Gujarat, India
Dhruvi Doshi GCS Medical College and Research Institute, Ahmedabad, Gujarat, India
Srikar Reddy Vummenthala Government Medical College Nalgonda, Nalgonda, Telangana, India
Vaishnavi Gummalla GITAM Institute of Medical Sciences and Research, Visakhapatnam, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20243071

Keywords:

Diabetes mellitus, Glucose, Insulin, Artificial pancreas

Abstract

Diabetes mellitus (DM) is one of the world's leading metabolic disorders, where extensive research on therapeutic management is going on. Artificial pancreas is an emerging novel therapeutic solution for diabetes mellitus based on the automatic insulin delivery system (AID). Medtronic's MiniMed 670G System (hybrid closed loop) was the first artificial pancreas approved by food and drug administration (FAD) and currently in clinical use. Efficiency, success rate, cost, and very less usage were few major barriers for an artificial pancreas. We described the basic structure, functions, limitations, and future of the artificial pancreas.

Metrics

Metrics Loading ...

References

PIppitt K, Li M, Gurgle HE. Diabetes mellitus: screening and diagnosis. Am Fam Physician. 2016;93(2):103-9.

MN Piero, G.M. Nzaro, J.M. Njagi. Diabetes mellitus-a devastating metabolic disorder. Asian J Biomed Pharma Sci; 04 (40); 20141-7.

IDF DIABETES ATLAS Ninth edition 2019. International Diabetes Federation. Available at: https://www.diabetesatlas.org/upload/resources/material. Accessed on 27th December 2020.

The Artificial pancreas device system. us food and drug administration. Available at: https://www.fda.gov/medical-devices/artificial. Accessed on 27th December 2020.

Diabetes. WHO Media centre Facts Sheets. 2013. Available from: https://web.archive.org/web. Accessed on 27th December 2020.

Sawyer B, Hilliard E, Hackney KJ, Stastny S. Barriers and strategies for type 1 diabetes management among emerging adults: a qualitative study. Clin Med Insights Endocrinol Diabetes. 2022;15:1179.

Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention-a review. Available at: https://pubmed.ncbi.nlm.nih.gov.

Boughton CK, Hovorka R. Advances in artificial pancreas systems. Science translational medicine. 2019;11(484):49.

Bekiari E, Kitsios K, Thabit H, Tauschmann M, Athanasiadou E, Karagiannis T, et al. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ. 2018;361:1310.

Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Lancet Diabetes Endocrinol. 2017;5(7):501-12.

National institute of diabetes and digestive and kidney diseases. Artificial Pancreas-NIDDK. Available from: https://www.niddk.nih.gov.

Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV, et al. Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes. JAMA. 2016;316(13):1407-8.

JDRF Celebrates FDA approval of artificial pancreas system. Available at: https://www.jdrf.org/press.

Artificial pancreas: what you should know. Healthline. Available from: https://www.healthline. Accessed on 27th December 2020.

The miracle of an artificial pancreas. NIH Medline Plus Magazine. Available at: https://magazine.medlineplus.gov/article. Accessed on 27th December 2020.

Bekiari E, Kitsios K, Thabit H, Tauschmann M, Athanasiadou E, Karagiannis T, et al. Artificial pancreas treatment for out-patients with type 1 diabetes: systematic review and meta-analysis. BMJ 2018;361:1310.

What is an artificial pancreas? WebMD. Available at :https://www.webmd.com/diabetes. Accessed on 27th December 2020.

Cobelli C, Renard E, Kovatchev B. Artificial pancreas: past, present, future. Diabetes. 2011;60 (11):2672-82.

Kapil S, Saini R, Wangnoo S, Dhir S. Artificial pancreas system for type 1 diabetes-challenges and advancements. Explore Res Hypothesis Med. 2020;5(3):110.

Pupelis G. Artificial pancreas: an overview. J Pancreas. 2020;21(5):95.

Haidar A. Insulin-and-glucagon artificial pancreas versus insulin-alone artificial pancreas: a short review. Diabetes Spectrum. 2019;32(3):215-21.

DeBoer MD, Breton MD, Wakeman C, Schertz EM, Emory EG, Robic JL, et al. Performance of an artificial pancreas system for young children with type 1 diabetes. Diabetes Technol Therap. 2017;19(5):293-8.

Hernando ME, García-Sáez G, Gómez EJ, Pérez GC, Rodríguez HA. Automated insulin delivery: the artificial pancreas technical challenges. Am J Therap. 2020;27(1):62-70.

Rabasa LR. Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial. Diabetes Obes Metab. 2017;19(5):713-20.

Kim J, Kang K, Drogemuller CJ. Bioprinting an Artificial Pancreas for Type 1 Diabetes. Curr Diab Rep. 2019;19:53.